Mar 24, 2026
Compass CEO Kabir Nath discusses FDA openness to psychedelic drug development and trial results. Listen in as he explains how existing psychiatry infrastructure supports broader adoption.
Mar 23, 2026
Randall Stanicky shares the role of digital therapeutics amid health care’s consumer shift. Listen in as he covers market evolution, key partnerships and the impact on health care.
Mar 20, 2026
We examine the pressures on CROs – including regulation and macro shifts – with incoming CEO, Birgit Girshick. Hear her vision on key industry changes and where AI creates opportunity.
Mar 19, 2026
Dr. Shantanu Singh outlines how new data sharing initiatives are transforming scientific research. Hear what these techniques could mean for the future of the AI health care industry.
Mar 13, 2026
Amy Burroughs outlines Terns Pharma's journey towards chronic myeloid leukemia treatment. Listen in as she shares her non-conventional career path and her leadership insight.
Mar 13, 2026
People are using GenAI for therapy despite safety concerns. Hear from Dr. Jon R. Cohen how to solve for these risks so that AI might be employed as an effective tool for mental health.
Mar 12, 2026
We speak with Praxis CEO Marcio Souza on navigating FDA engagement amid government staffing challenges. Listen in as they discuss regulatory strategy, data-driven trials and investor signals
Mar 11, 2026
Adam Kautzner discusses Cigna’s shift to a rebate-free model and PBM reform. Hear how the company is exploring impacts on patients, employers, drugmakers, pharmacies and transparency.
Apr 02, 2025
Mike Cloonan shares his career from small start-ups to large corporations. Hear him reveal why he chose to lead Sionna and the importance of identifying the unmet needs of patients.
Mar 28, 2025
What does it take to become a leader in biotechnology? Hear from two top BioMarin exec how they intend to harness innovation and remain competitive to become a biotech bellwether.
Mar 26, 2025
Bringing consumers together with digital clinical programs online is its own science. Hear Ido Schoenberg share how Amwell effectively delivers that connection to everyone's benefit.
Mar 21, 2025
Like most industries, artificial intelligence is disrupting health care research. Listen to Kimberly Powell of Nvidia discuss digital innovation in imaging, drug discovery and more.
Mar 19, 2025
We speak with President and CEO, Sarah Boyce of Avidity Bioscience. As an industry leader in Life Sciences, hear her vision on patient-centered approaches to drug discovery.
Mar 17, 2025
In the first of our new series covering the TD Cowen Health Care Conference, hear Biogen CEO, Chris Viehbacher, share the ways biopharma has changed and the road to revenue growth.
Japan